Free Trial

PureTech Health (LON:PRTC) Stock Price Down 15.2% - Here's What Happened

PureTech Health logo with Medical background

PureTech Health plc (LON:PRTC - Get Free Report) shares were down 15.2% during trading on Tuesday . The stock traded as low as GBX 117.20 ($1.53) and last traded at GBX 117.20 ($1.53). Approximately 42,764,352 shares traded hands during mid-day trading, an increase of 2,645% from the average daily volume of 1,557,904 shares. The stock had previously closed at GBX 138.20 ($1.81).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reaffirmed a "buy" rating and issued a GBX 455 ($5.96) price objective on shares of PureTech Health in a report on Monday, December 16th.

View Our Latest Report on PureTech Health

PureTech Health Trading Up 14.6 %

The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. The firm's 50 day moving average is GBX 135.24 and its two-hundred day moving average is GBX 148.08. The stock has a market cap of £354.45 million, a price-to-earnings ratio of -4.84 and a beta of 1.02.

PureTech Health Company Profile

(Get Free Report)

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.

Recommended Stories

Should You Invest $1,000 in PureTech Health Right Now?

Before you consider PureTech Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.

While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines